Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  De Rosa, Francesco G ^a   Motta, Ilaria ^a   Audisio, Ernesta ^b   Frairia, Chiara ^b   Busca, Alessandro ^b   Di Perri, Giovanni ^a   Marmont, Filippo ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

Acute myeloid leukemia; Chemotherapy; Febrile neutropenia; Infections; Levofloxacin prophylaxis; Neutropenia

Indexed keywords

AMIKACIN; AMPICILLIN; CARBOPLATIN; CEFTAZIDIME; CEFTRIAXONE; CYTARABINE; ETOPOSIDE; EXTENDED SPECTRUM BETA LACTAMASE; IFOSFAMIDE; ITRACONAZOLE; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEICOPLANIN; VANCOMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BLOOD CULTURE; BLOODSTREAM INFECTION; CONSOLIDATION CHEMOTHERAPY; CORYNEBACTERIUM; DIET THERAPY; DISEASE DURATION; DRUG MEGADOSE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENZYME SYNTHESIS; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEBRILE NEUTROPENIA; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITALIZATION; HUMAN; INDUCTION CHEMOTHERAPY; LUNG ASPERGILLOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; MULTICENTER STUDY (TOPIC); MULTIPLE CYCLE TREATMENT; MYCOSIS; NEUTROPENIA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RETROSPECTIVE STUDY; YOUNG ADULT;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; BACTERIA; BACTERIAL INFECTIONS; CIPROFLOXACIN; FEMALE; FLUOROQUINOLONES; HUMANS; INCIDENCE; LEUKEMIA, MYELOID, ACUTE; LEVOFLOXACIN; MALE; MIDDLE AGED; NEUTROPENIA; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84888390553     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-563     Document Type: Article

References (14)

1. Han LN, Zhou J, Shuringa JJ, Vellenga E. Treatment strategies in acute myeloid leukemia. Chin Med J (Engl) 2011, 124(9):1409-1421.
2. Roboz GJ. Novel approaches to the treatment of acute myeloid leukemia. Hematology Am Soc Hematol Educ Program 2011, 2011:43-50. 10.1182/asheducation-2011.1.43, 22160011.
3. Freifeld AG, Bow EJ, Sepkowitz KA, et al. IDSA guidelines clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis 2010, 52(4):e56-e93.
4. Rolston KV. New trends in patient management: risk-based therapy for febrile patients with neutropenia. Clin Infect Dis 1999, 29:515-521. 10.1086/598624, 10530438.
5. Bucaneve G, Micozzi A, Menichetti F, et al. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med 2005, 353:977-987. 10.1056/NEJMoa044097, 16148283.
6. Gafter-Gvili A, Fraser A, Paul M, et al. Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy. Cochrane Database Syst Rev 2012, 1:25-27.
7. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998, 26:781-805. 10.1086/513943, 9564455.
8. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002, 34:7-14. 10.1086/323335, 11731939.
9. Corey L, Boeckh M. Persistent fever in patients with neutropenia. N Engl J Med 2002, 346:222-224. 10.1056/NEJM200201243460402, 11807145.
10. Chen CY, Tsay W, Tang GL, et al. Epidemiology of bloodstream infections in patients with hematological malignancies with and without neutropenia. Epidemiol Infect 2010, 138:1044-1051. 10.1017/S0950268809991208, 19941686.
11. Intermesoli T, Oldani E, Rossi G, et al. Two-step response-oriented induction predicts long-term outcome of adult patients with standard- and high-risk acute myeloid leukaemia (AML): a Northern Italy Leukaemia Group (NILG) study. Abstracts of the Fifteenth EHA Annual Meeting 2010, Barcelona: Abstract 649. European Hematology Association.
12. De Rosa FG, Pagani N, Fossati L, et al. The effect of inappropriate therapy on bacteremia by ESBL-producing bacteria. Infection 2011, 39(6):555-561. 10.1007/s15010-011-0201-x, 22048926.
13. Busca A, Cavecchia I, Locatelli F, et al. Blood stream infections after allogeneic stem cell transplantation: a single-center experience with the use of levofloxacin prophylaxis. Transpl Infect Dis 2012, 14(1):40-48. 10.1111/j.1399-3062.2011.00650.x, 21599817.
14. Tumbarello M, Trecarichi EM, Bassetti M, et al. Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. Antimicrob Agents Chemother 2011, 55(7):3485-3490. 10.1128/AAC.00009-11, 3122446, 21537020.